Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-12Clinical Trial Update: Comparing TR Band to Statseal in Conjunction With TR Band [NA]
A completed clinical trial comparing TR Band to Statseal used in conjunction with TR Band for arterial occlusion and angina pectoris; result…
-
CLINICAL_TRIALS trial_result · 2018-03-09Clinical Trial Update: Improving Intermediate Risk Management. MARK Study
The MARK Study trial has completed, reporting results on intermediate risk management in patients with myocardial infarction, angina pectori…
-
CLINICAL_TRIALS trial_result · 2018-03-08Clinical Trial Update: EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease [Phase 1]
Phase 1 trial of VEGF-D gene therapy delivered endocardially for severe coronary heart disease has completed, enrolling patients with angina…
-
FDA approval · 2018-01-26FDA Approved: KAPSPARGO — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved KAPSPARGO (metoprolol succinate) through an original new drug application by Sun Pharmaceutical Industries, marking regulatory …
-
FDA approval · 2018-01-24FDA Approved: NITROSTAT — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for NITROSTAT (nitroglycerin) submitted by Viatris Specialty LLC, resulting in changes associate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-12-19FDA Approved: NIFEDIPINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a generic nifedipine product by Zydus Lifesciences Limited. The approval covers nifedipine for the…
-
FDA approval · 2017-12-13FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride filed by Hospira, Inc., signaling an additional approval related to the …
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Ranolazine Among Unrevascularized Chronic Stable Angina Patients [Phase 2]
Phase 2 clinical trial update for ranolazine in unrevascularized chronic stable angina; results posted after completion.
-
FDA approval · 2017-11-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for verapamil hydrochloride from Chartwell RX, LLC.
-
FDA label_change · 2017-10-30FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA granted a supplemental approval for Norvasc (amlodipine besylate) filed by Viatris Specialty LLC, resulting in labeling changes.
-
FDA approval · 2017-09-19FDA Approved: NITROGLYCERIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original application for nitroglycerin from Glenmark Pharmaceuticals Inc., USA, granting a generic nitroglycerin product ma…
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery [NA]
A completed clinical trial evaluating rigid sternal fixation to support bone healing and improve postoperative recovery.
-
FDA approval · 2017-08-11FDA Approved: TIADYLT ER — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approves TIADYLT ER (diltiazem hydrochloride extended-release) from Zydus Pharmaceuticals (USA) Inc. under an original ANDA, providing a…
-
FDA approval · 2017-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved Zydus Pharmaceuticals USA's original application for diltiazem hydrochloride as a generic product, enabling its use for the man…
-
FDA approval · 2017-07-28FDA Approved: NADOLOL — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved Nadolol as a generic drug in an Original Application (ANDA) for Zydus Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD [Phase 3]
A Phase 3 clinical trial assessing the effect of ranolazine on coronary flow reserve in symptomatic diabetic patients with coronary artery d…
-
FDA approval · 2017-06-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's diltiazem hydrochloride as a generic product under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis
An update on the Onyx zotarolimus-eluting stent for coronary artery disease, focusing on its effect and efficacy. The current trial status i…
-
FDA approval · 2017-05-05FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved the original application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc. as a generic product.
-
FDA approval · 2017-03-30FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC. The action confirms regula…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions [Phase 1]
Phase 1 relative bioavailability study of Nadolol 80 mg tablets under fasting conditions has completed. The study investigates the pharmacok…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina [Phase 3]
Phase III trial of Dantonic (T89) Capsule for prevention and treatment of stable angina has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina [Phase 3]
A Phase 3 trial assessing intramyocardial delivery of autologous CD34+ stem cells for improving exercise capacity in subjects with refractor…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents [NA]
A clinical trial update comparing the bioresorbable polymer Orsiro stent to the durable polymer Resolute Onyx stent in patients with coronar…
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity [NA]
A clinical trial update comparing the Promus Element versus Resolute Integrity drug-eluting stents in coronary artery disease, with the tria…